ArticleBlood advances2022

Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials.

Zachariah DeFilipp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.